News and Press Releases
Press releases
Dr. Ashish M. Kamat Joins Theralase Medical and Scientific Advisory Board
Press ReleaseToronto, Ontario – December 2, 2014 Theralase Technologies Inc. (“Theralase”) (TLT:TSXV) (TLTFF: OTC Link®) announced today that Ashish M. Kamat, MD, MBBS, FACS, has agreed to join the Theralase Medical and Scientific Advisory Boa...
Theralase Releases 3Q2014 Financials
Press ReleaseToronto, Ontario – November 28, 2014 Theralase Technologies Inc. (“Theralase”) (TLT: TSXV) (TLTFF: OTC Link®) released its third quarter 2014 financial results today, demonstrating a decrease in revenue for the three month period ...
Theralase Releases Annual General Meeting Video
Press ReleaseToronto, Ontario – November 25, 2014 Theralase Technologies Inc. (“Theralase”) (TSXV: TLT) (TLTFF: OTCBB) announced today that it has released a video of the presentations conducted at the Theralase 2013 Annual General Meeting (“...
Theralase Further Validates Anti-Cancer Memory Response
Press ReleaseToronto, Ontario – November 12, 2014 Theralase Technologies Inc. (“Theralase”) (TSXV: TLT) (TLTFF: OTCBB) announced today that in new preclinical research, conducted at Princess Margaret Cancer Centre, University Health Network (...
Theralase Presents Latest Research on Destruction of Cancer and Bacteria at International Conference
Press ReleaseToronto, Ontario – October 16, 2014 –Theralase Technologies Inc. (“Theralase®”) (TSXV: TLT) (TLTFF: OTC Link®) announced today that it has presented its latest research on the success of its Photo Dynamic Compounds (“PDCs”)...
Theralase Partners with SAFC in Manufacture of Anti-Cancer Drugs
Press ReleaseToronto, Ontario – October 7, 2014 –Theralase Technologies Inc. (“Theralase®”) (TSXV: TLT) (TLTFF: OTC Link®) announced today that it has collaborated with Sigma-Aldrich Corporation’s (NASDAQ: SIAL) custom manufacturing servi...
Theralase Files Voluntary Annual Information Form
Press ReleaseToronto, Ontario – September 24, 2014 –Theralase Technologies Inc. (“Theralase®”) (TSXV: TLT) (TLTFF: OTC Link®) announced today that it has filed a voluntary Annual Information Form (“AIF”) as part of its corporate strateg...
Theralase Partners with Montreal’s JSS Medical Research to Bring Innovative Bladder Cancer Treatment to Market
Press ReleaseToronto, Ontario / ACCESSWIRE / September 11, 2014 / To take advantage of the vastly improved business climate in Quebec, Theralase Technologies Inc. (“Theralase”) (TLT.V) (TLTFF: OTC Link(R)) announced today that it is partnering with J...
Theralase Launches Multi Wavelength Laser for Cancer Destruction
Press ReleaseToronto, Ontario / ACCESSWIRE / September 9, 2014 / Theralase Technologies Inc. (“Theralase”) (TLT.V) (TLTFF: OTC Link(R)) announced today that it has successfully launched its TLC-3000 multi wavelength laser system capable of activating...
Theralase Releases 2Q2014 Financials
Press ReleaseToronto, Ontario / ACCESSWIRE / August 29, 2014 / Theralase Technologies Inc. (“Theralase”) (TLT:TSXV) (TLTFF:OTC Link) released its second quarter 2014 financial results today, demonstrating a slight increase in revenue for the three mo...
in the news
July 6, 2023
Vrian Crombie Radio Interview with Roger DuMoulin-White - President and Chief Executive Officer
may 18, 2023
Promising Developments in the Theralase® Project of Intravesical Photodynamic Therapy for BCG Unresponsive Bladder Cancer - Girish Kulkarni
